Literature DB >> 22188935

Whither monkeypox vaccination.

Anne W Rimoin1, Barney S Graham.   

Abstract

Monkeypox (MPX) is a virulent orthopoxvirus that is endemic in some regions of Central Africa. MPX incidence has been rising since the cessation of routine smallpox immunization. While it causes significant disease, there is limited person-to-person spread, the incidence is still relatively low, and cases are generally restricted to remote areas that are difficult to access. Therefore, initiating vaccine trials or implementing vaccination programs would be challenging. This paper considers the factors that may influence future decisions on whether MPX vaccination should be pursued. Published by Elsevier Ltd.

Entities:  

Keywords:  Orthopoxvirus; biodefense; smallpox; vaccine; variola

Mesh:

Year:  2011        PMID: 22188935      PMCID: PMC3311705          DOI: 10.1016/j.vaccine.2011.09.004

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  Monkeypox and its relevance to smallpox eradication.

Authors:  D A Henderson; I Arita
Journal:  WHO Chron       Date:  1973-04

Review 2.  Smallpox and its post-eradication surveillance.

Authors:  Z Jezek; L N Khodakevich; J F Wickett
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 3.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  Human monkeypox: a study of 2,510 contacts of 214 patients.

Authors:  Z Jezek; S S Marennikova; M Mutumbo; J H Nakano; K M Paluku; M Szczeniowski
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

5.  Human monkeypox: secondary attack rates.

Authors:  Z Jezek; B Grab; M V Szczeniowski; K M Paluku; M Mutombo
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

6.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

7.  A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo.

Authors:  I D Ladnyj; P Ziegler; E Kima
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

8.  Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.

Authors:  Tomoya Saito; Tatsuya Fujii; Yasuhiro Kanatani; Masayuki Saijo; Shigeru Morikawa; Hiroyuki Yokote; Tsutomu Takeuchi; Noriyuki Kuwabara
Journal:  JAMA       Date:  2009-03-11       Impact factor: 56.272

Review 9.  Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

Authors:  Nancy J Sullivan; Julie E Martin; Barney S Graham; Gary J Nabel
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

Review 10.  Smallpox vaccines: Past, present, and future.

Authors:  Janie Parrino; Barney S Graham
Journal:  J Allergy Clin Immunol       Date:  2006-12       Impact factor: 14.290

View more
  2 in total

1.  Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Authors:  Graham J Hatch; Victoria A Graham; Kevin R Bewley; Julia A Tree; Mike Dennis; Irene Taylor; Simon G P Funnell; Simon R Bate; Kimberley Steeds; Thomas Tipton; Thomas Bean; Laura Hudson; Deborah J Atkinson; Gemma McLuckie; Melanie Charlwood; Allen D G Roberts; Julia Vipond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

Review 2.  Vaccinating against monkeypox in the Democratic Republic of the Congo.

Authors:  Brett W Petersen; Joelle Kabamba; Andrea M McCollum; Robert Shongo Lushima; Emile Okitolonda Wemakoy; Jean-Jacques Muyembe Tamfum; Beatrice Nguete; Christine M Hughes; Benjamin P Monroe; Mary G Reynolds
Journal:  Antiviral Res       Date:  2018-11-14       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.